HK Stock MarketDetailed Quotes
01011 NT PHARMA
- 0.020
- -0.002-9.09%
Market Closed Jun 7 18:26 CST
52.82MMarket Cap-333P/E (TTM)
0.022High0.020Low1.08MVolume0.021Open0.022Pre Close22.42KTurnover0.04%Turnover RatioLossP/E (Static)2.64BShares0.10252wk High-0.14P/B52.82MFloat Cap0.01752wk Low--Dividend TTM2.64BShs Float4.220Historical High--Dividend LFY9.09%Amplitude0.017Historical Low0.020Avg Price500Lot Size--Div YieldTTM--Div Yield LFY
NT PHARMA Key Stats
All
YOY
| (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | --7.37M | -31.45%82.61M | ---- | 8.33%120.5M | 2.24%226.7M | 24.37%111.23M | 44.48%221.73M | -4.88%89.44M | -73.15%153.47M | -69.86%94.02M |
| Operating income | 7.37M | -31.45%82.61M | 8.33%120.5M | 2.24%226.7M | 24.37%111.23M | 44.48%221.73M | -4.88%89.44M | -73.15%153.47M | -69.86%94.02M | |
| Cost of sales | ---- | 33.58%-30.31M | ---- | -15.31%-45.63M | 6.43%-81.24M | -20.87%-39.57M | -37.36%-86.83M | 0.15%-32.74M | 57.72%-63.21M | 53.72%-32.79M |
| Operating expenses | 33.58%-30.31M | -15.31%-45.63M | 6.43%-81.24M | -20.87%-39.57M | -37.36%-86.83M | 0.15%-32.74M | 57.72%-63.21M | 53.72%-32.79M | ||
| Gross profit | -30.14%52.3M | 4.48%74.87M | 7.82%145.46M | 26.39%71.66M | 49.47%134.9M | -7.41%56.7M | -78.61%90.26M | -74.61%61.24M | ||
| Selling expenses | ---- | 77.36%-11.04M | ---- | 7.04%-48.75M | ---- | -36.47%-52.44M | ---- | 6.39%-38.43M | ---- | 17.97%-41.05M |
| Administrative expenses | -181.03%-63.57M | 7.36%-24.39M | ---22.62M | 27.21%-26.33M | ---- | 18.53%-36.18M | ---- | -16.91%-44.4M | ---- | 26.53%-37.98M |
| Profit from asset sales | --12.27M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16,209.09%1.79M | ---- | -99.75%11K |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 16,209.09%1.79M | ---- | -99.75%11K |
| Impairment and provision | ---- | ---- | ---3.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | ---- | ---3.92M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | -65.82%2.35M | 46.36%11.4M | -65.98%6.86M | -82.79%7.79M | -25.27%20.18M | 1,468.98%45.27M | 1,046.94%27M | 163.84%2.89M | 97.32%2.35M | -264.14%-4.52M |
| Operating profit | -111.35%-41.59M | 272.89%28.28M | -111.88%-19.68M | -73.21%7.58M | 2.31%165.64M | 231.97%28.31M | 74.82%161.9M | 3.80%-21.45M | -78.12%92.61M | -115.65%-22.3M |
| Financing cost | 26.79%-28.82M | 2.82%-33.89M | 55.63%-39.37M | -9.30%-34.87M | -2.53%-88.73M | -17.96%-31.9M | 17.09%-86.54M | -22.24%-27.05M | -28.77%-104.38M | 15.83%-22.13M |
| Share of profits of associates | 311.41%37.04M | ---- | -73.90%9M | ---- | 431,025.00%34.49M | ---- | 129.63%8K | ---- | 98.63%-27K | ---- |
| Special items of earning before tax | ---- | ---- | ---- | ---- | 5.63%-260.15M | ---- | 19.71%-275.66M | ---- | 61.94%-343.35M | ---- |
| Earning before tax | 33.32%-33.37M | 79.43%-5.61M | 66.36%-50.04M | -659.29%-27.29M | 25.73%-148.75M | 92.59%-3.59M | 43.60%-200.29M | -9.17%-48.5M | 36.81%-355.14M | -138.24%-44.43M |
| Tax | ---122K | ---- | ---- | ---949K | -128.63%-2.58M | ---- | 3,503.77%9.02M | ---- | 99.34%-265K | 99.51%-50K |
| After-tax profit from continuing operations | 33.07%-33.49M | 80.13%-5.61M | 66.93%-50.04M | -685.70%-28.24M | 20.88%-151.33M | 92.59%-3.59M | 46.18%-191.27M | -9.04%-48.5M | 40.95%-355.41M | -142.00%-44.48M |
| After-tax profit from non-continuing business | -572.77%-110.1M | ---- | ---16.37M | ---- | ---- | ---- | 29.08%-168.64M | -175.68%-36.46M | 34.29%-237.8M | 323.37%48.18M |
| Earning after tax | -116.23%-143.59M | 80.13%-5.61M | 56.12%-66.41M | -685.70%-28.24M | 57.95%-151.33M | 95.77%-3.59M | 39.33%-359.91M | -2,396.24%-84.96M | 38.45%-593.2M | -95.61%3.7M |
| Minority profit | ---- | ---- | ---- | ---- | 22.39%-1.8M | 46.41%-940K | 58.77%-2.31M | -66.89%-1.75M | 7.94%-5.61M | -175.67%-1.05M |
| Shareholders should account for profits from continuing business | 33.07%-33.49M | ---- | ---50.04M | ---- | ---- | ---- | ---- | ---46.75M | ---349.79M | ---- |
| Shareholders should account for profits from non-continuing business | -572.77%-110.1M | ---- | ---16.37M | ---- | ---- | ---- | ---- | ---36.46M | ---237.8M | ---- |
| Profit attributable to shareholders | -116.23%-143.59M | 80.13%-5.61M | 55.59%-66.41M | -963.98%-28.24M | 58.18%-149.54M | 96.81%-2.65M | 39.14%-357.6M | -1,851.36%-83.21M | 38.64%-587.59M | -94.27%4.75M |
| Basic earnings per share | -108.02%-0.0726 | 83.22%-0.0025 | 55.88%-0.0349 | -964.29%-0.0149 | 58.26%-0.0791 | 96.80%-0.0014 | 43.11%-0.1895 | -1,660.71%-0.0437 | 45.54%-0.3331 | -94.70%0.0028 |
| Diluted earnings per share | -108.02%-0.0726 | 83.22%-0.0025 | 55.88%-0.0349 | -964.29%-0.0149 | 58.26%-0.0791 | 96.80%-0.0014 | 43.11%-0.1895 | -1,660.71%-0.0437 | 45.54%-0.3331 | -93.75%0.0028 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Dahua Ma Shiyun Certified Public Accountants Co., Ltd. | -- | Guofi Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofi Haohua (Hong Kong) Certified Public Accountants Limited | -- | Guofi Haohua (Hong Kong) Certified Public Accountants Limited | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg